Re: Crispr therapudics beta thal reminder
I'm getting concerned over Pfizer stock price. They bought Hospira which is the motherload supplier for infusion therapy. When Pfizer gt manufacturing shifts into gear they will be dosing to the max. Vertical integration. They also have mylans EpiPen. They will need to buy Sangamo to keep their GT alive. Running from Sangamo will only last so long. They are caught in a stranglehold. Sangamo long term Gene editing will Trump their durability. Kathy Yi left Sangamo in a loof unaware and in a daze of confusion with her mind on Europe.